arrow
Back
S

Silvia Novello

university of turin

87H-index
1.0KPaper Count
4.8WCitation Count
Published Papers 258
Publication Date
High Prevalence of Superficial Metastases Supports Percutaneous Ultrasound-Guided Biopsy for Diagnosis and Molecular Profiling of Advanced Lung Cancer: Results from a Prospective Cohort
errCancers
IF4.4
err2026-07-23
err0
errOAAI
errMarta Viscuso; Vanina Livi; Giovanni Sotgiu; Valeria Cetoretta; Alessandra Cancellieri; Mariangela Puci; Angelo Minucci; Emilio Bria; Federico Cappuzzo; Silvia Novello; Rocco Trisolini
errShare
errSave
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial
err2026-07-06
err0
errOAAI
errMassimiliano Cani; Daniela Bafunno; Francesca Caumo; Silvia Novello; Salvatore Cardellicchio; Vincenzo Cilenti; Elena Davoli; Edoardo Mercadante; Ciro Battiloro; Aldo Cammarota; Sandro Sironi; Vito Barbieri; Vito Ladisa; Roberto Boffi; Beatrice Cosentino; Mariam El Hayek; Ugo Pastorino
errShare
errSave
Response to Letter Re: Real-World Outcomes of Immunotherapy Discontinuation at Two Years in Advanced Non-Small Cell Lung Cancer: final results of the ISTOP study.
err2026-05-02
err0
PREAI
errMaria Gemelli; Luca Sala; Alessandro Morabito; Vincenzo Sforza; Alessio Cortellini; Giulia La Cava; Federica Bertolini; Giorgia Guaitoli; Simona Carnio; Silvia Novello; Alessandro Leonetti; Marcello Tiseo; Francesca Mazzoni; Federica Cosso; Marianna Macerelli; Alexandro Membrino; Giulio Metro; Rita Chiari; Carlo Genova; Rossana Berardi
errShare
errSave
Lung cancer in women: current evidence and future research priorities
err2026-01-04
err0
PREAI
errMonireh Sadat Seyyedsalehi; Massimiliano Cani; Qian Wang; Chitra Thakur; Umberto Malapelle; Chung Yin Kong; Silvia Novello; Paolo Boffetta
errShare
errSave
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%
err2025-11-17
err0
errOAAI
errA. De Giglio; L. Zullo; A. Di Federico; M. Cani; M. Aldea; D. Soldato; F.G. Dall’Olio; F. Mantuano; F. Sperandi; V. Favorito; A. Sadowska; L.E.L. Hendriks; T. Gorria; L. Mezquita; F. Tabbò; S. Novello; F. Gelsomino; B. Besse; A. Ardizzoni
errShare
errSave
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671
err2025-11-05
err0
PREAI
errMoishe Liberman; David R. Jones; Heather Wakelee; Shugeng Gao; Balazs Halmos; Ernest Nadal; Anna Łowczak; Martin Reck; Silvia Novello; Danielli Matias; Alexander Luft; Rina Hui; Se-Hoon Lee; Masahiro Tsuboi; Terufumi Kato; Yuming Zhu; Benny Weksler; Erin Jensen; Ayman Samkari; Steven M. Keller; Jonathan D. Spicer
errShare
errSave
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
err2025-10-30
err0
PREAI
errJessica Menis; Laurent Greiller; Pierre Demontrond; Isabelle Monnet; Silvia Novello; Lorenzo Livi; Robin Young; Chantal Decroisette; Nicolas Cloarec; Gilles Robinet; Roland Schott; Jerome Fayette; Giuseppe Luigi Banna; Filippo De Marinis; Raffaele Califano; Boris Duchemann; Andrea Luciani; Ida Colantonio; Beatrice Fournier; Yassin Pretzenbacher; Caroline Caramella; Mario Silva; Thierry Berghmans; Anne-Marie Dingemans; Paolo Bironzo; Jonathan Tugwood; Cong Zhou; Steven Hill; Kieran Bradbury; Karen Morris; Elaine Kilgour; Caroline Dive; Fiona Blackhall; Benjamin Besse
errShare
errSave
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study
err2025-10-16
err0
PREAI
errIgor Gomez-Randulfe; Federico Monaca; Ornella Cantale; Maria Lucia Reale; Loredana Mrak; Lodovica Zullo; Sofia Silva Diaz; Marta Zaragoza Bueno; Marya Alejandra Maridueña Moreno; Charlotte Davis; Samantha Cox; Daniel Lee; Riyaz Shah; Tom Geldart; Javier Baena; Jose Carlos Benitez; M.A. Rosario Garcia Campelo; Jordi Remon; David Planchard; Domenico Galetta; Marcello Tiseo; Diego Cortinovis; Giulio Metro; Emilio Bria; Francesco Passiglia; Silvia Novello; Raffaele Califano
errShare
errSave
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
err2025-09-24
err0
errOAAI
errMaria Lucia Reale; Daniela Scattolin; Antonio Vitale; Francesco Passiglia; Salvatore Grisanti; Marianna Macerelli; Domenico Galetta; Claudio Sini; Gabriele Minuti; Fabrizio Citarella; Elisa Roca; Francesco Agustoni; Alessandra Dodi; Diego Cortinovis; Lorenzo Belluomini; Serena Ricciardi; Antonello Veccia; Elio Gregory Pizzutilo; Vieri Scotti; Greta Alì; Francesca Mazzoni; Alessandro Russo; Daniele Pignataro; Alessandra Bulotta; Pierluigi Piovano; Concetta Sergi; Anna Bettini; Carlo Genova; Alberto Pavan; Hector José Soto Parra; Cinzia Ortega; Daniele Pozzessere; Tiziana Vavalà; Rita Chiari; Cristina Zannori; Alessandro D’Aveni; Giulia Meoni; Diana Giannarelli; Umberto Malapelle; Silvia Novello; Emilio Bria; Giulia Pasello
errShare
errSave
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial
err2025-09-01
err0
PREAI
errJordi Remon; Paolo Bironzo; Nicolas Girard; Laurence Bigay-Game; Oscar Juan-Vidal; Javier de Castro; Noemí Reguart; Laurent Greillier; Sophie Cousin; Eric Dansin; Margarita Majem; Reyes Bernabé; Joaquin Mosquera Martinez; Marta Díaz; Alba Meya; Daniel Alcalá-López; Alicia García-Sanz; Luisella Righi; Silvia Novello; Benjamin Besse
errShare
errSave
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
err2025-06-25
err0
PREAI
errFederico Monaca; Igor Gomez-Randulfe; Gerard Walls; Ornella Cantale; Ana Parreira; Sara Polidori; Mariantonietta Di Salvatore; Vito Longo; Domenico Galetta; Emanuele Vita; Antonella Martino; Maria Antonietta Gambacorta; Luca Boldrini; Yvonne Summers; Giampaolo Tortora; Fiona Blackhall; Silvia Novello; Clara Chan; Emilio Bria; Corinne Faivre-Finn; Raffaele Califano
errShare
errSave
The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysis
err2025-06-18
err0
PREAI
errCarlo Genova; Federico Cappuzzo; Giorgio Minotti; Nicola Normanno; Barry Rodgers-Gray; Nicola Waghorne; Silvia Novello; Marcello Tiseo
errShare
errSave
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer
err2025-06-11
err0
errOAAI
errMarina C. Garassino; Ying Cheng; Delvys Rodriguez-Abreu; Silvia Novello; Julien Mazieres; Andrew G. Robinson; Steven F. Powell; Balazs Halmos; Jhanelle E. Gray; Meihua Wang; Cong Chen; Jing Yang; Fabricio Souza; Paul Schwarzenberger; Luis Paz-Ares
errShare
errSave
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)
err2025-06-01
err0
PREAI
errFacchinetti, Francesco; Camerini, Andrea; Bennati, Chiara; Bordi, Paola; De Carlo, Elisa; Mazzoni, Francesca; Metro, Giulio; Bertolini, Federica; Longo, Lucia; Ricciardi, Serena; Pilotto, Sara; Giardina, Donatella; Passiglia, Francesco; Scotti, Vieri; Piacentini, Paolo; Frega, Stefano; Calabro, Luana; Guida, Annalisa; Grosso, Maria Antonietta; Longobardi, Jenny; Merlini, Alessandra; Cosso, Federica; Leonetti, Alessandro; Gariazzo, Eleonora; Guaitoli, Giorgia; Belluomini, Lorenzo; Bearz, Alessandra; Tognetto, Michele; Bria, Emilio; Cortinovis, Diego Luigi; Novello, Silvia; Di Maio, Massimo; Tiseo, Marcello
errShare
errSave
Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma
err2024-12-21
err0
errOAAI
errSalaroglio, I. C.; Aviles, P.; Kopecka, J.; Merlini, A.; Napoli, F.; Righi, L.; Novello, S.; Sullivan, H.; Cuevas, C.; Scagliotti, G. V.; Riganti, C.
errShare
errSave
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC
err2024-11-01
err5
PREAI
errNakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin
errShare
errSave
IMpower010: ctDNA status and 5y DFS follow up in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC)
err2024-09-01
err1
PREAI
errWakelee, H.; Reck, M.; Felip, E.; Altorki, N. K.; Vallieres, E.; Liersch, R.; Oizumi, S.; Tanaka, H.; Hamm, J. T.; McCune, S.; Bennett, E.; Gitlitz, B. J.; McNally, V. A.; Novello, S.; Ballinger, M.; Zou, W.; Nabet, B.; Srivastava, M.; Zhou, C.
errShare
errSave
Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
err2024-09-01
err0
PREAI
errReale, M. L.; Scattolin, D.; Bria, E.; Vitale, A.; Grisanti, S.; Costa, J.; Galetta, D.; Sini, C.; Minuti, G.; Citarella, F.; Roca, E.; Agustoni, F.; Tiseo, M.; Cortinovis, D. L.; Pilotto, S.; Ricciardi, S.; Passiglia, F.; Malapelle, U.; Novello, S.; Pasello, G.
errShare
errSave
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
errLANCET
IF88.5
err2024-09-01
err4
PREAI
errSpicer, Jonathan D.; Garassino, Marina C.; Wakelee, Heather; Liberman, Moishe; Kato, Terufumi; Tsuboi, Masahiro; Lee, Se-Hoon; Chen, Ke-Neng; Dooms, Christophe; Majem, Margarita; Eigendorff, Ekkehard; Martinengo, Gaston L.; Bylicki, Olivier; Rodriguez-Abreu, Delvys; Chaft, Jamie E.; Novello, Silvia; Yang, Jing; Arunachalam, Ashwini; Keller, Steven M.; Samkari, Ayman; Gao, Shugeng
errShare
errSave
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer (vol 43, 219, 2024)
err2024-08-29
err0
errOAAI
errAkman, Muhlis; Monteleone, Ciro; Doronzo, Gabriella; Godel, Martina; Napoli, Francesca; Merlini, Alessandra; Campani, Virginia; Nele, Valeria; Balmas, Elisa; Chontorotzea, Tatiana; Fontana, Simona; Digiovanni, Sabrina; Barbu, Francesca Alice; Astanina, Elena; Jafari, Niloufar; Salaroglio, Iris Chiara; Kopecka, Joanna; De Rosa, Giuseppe; Mohr, Thomas; Bertero, Alessandro; Righi, Luisella; Novello, Silvia; Scagliotti, Giorgio Vittorio; Bussolino, Federico; Riganti, Chiara
errShare
errSave